Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood
Main Article Content
Abstract
Inflammatory bowel disease (IBD) is a term for two autoimmune diseases encompassing Crohn’s disease (CD) and ulcerative colitis (UC) which are lifelong diseases affecting more than 3 million adults (1.3%) in the United States. IBD is characterized by chronic inflammation of the whole digestive system which results in damage to the gastrointestinal (GI) tract. IBD often emerges during adolescence and young adulthood. Maternal morbidity includes physical and psychological conditions that result from or are aggravated by pregnancy and have an adverse effect on a woman’s health, the baby’s health or both. Some women have health challenges that arise before or during pregnancy that could lead to complications. It is recommended for women to receive health care counseling before and during pregnancy. Compared to other developed countries, the United States has the highest rate of women dying of pregnancy related complications. During the past 25 years maternal mortality has been getting worse. African American women (AAW) with and/or without IBD are dying at significantly higher rates than other groups. This is linked to several factors, i.e., systemic, institutionalized, and structural racism in health-care delivery and subsequent toxic stress from people’s lived experiences of racism, limited knowledge about healthcare system function, lack of access to healthcare, (inclusiveness and insurance policies) all of which negatively impact these patients. African Americans (AAs) are also up to three times as likely to experience severe maternal morbidity: unexpected outcomes of labor and delivery, deficient or lacking prenatal care and social determinants of health like lack of transportation, adequate employment, limited literacy, and limited healthcare access contribute to poor health outcomes. Studies on IBD patients indicate Medicaid expansion is associated with reduced rates of maternal morbidity, particularly for African American Women (AAW) and increased access to preconception and prenatal services that make pregnancy and childbirth safer for parent and baby. Herein we examine the physiological changes of pregnancy in patients diagnosed with inflammatory bowel disease and their relationship perinatal outcomes and parenthood.
Article Details
How to Cite
M'KOMA, Amosy E. et al.
Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood.
Medical Research Archives, [S.l.], v. 11, n. 6, june 2023.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/3784>. Date accessed: 26 dec. 2024.
doi: https://doi.org/10.18103/mra.v11i6.3784.
Section
Review Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. M'Koma A E. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointest Disord. 2018;1(1):75-105.
2. Siegmund B, Zeitz M. [Inflammatory bowel disease and pregnancy]. Z Gastroenterol. 2009;47(10):1069-74.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417-29.
4. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14(1):15-9.
5. Sands BE. Therapy of inflammatory bowel disease. Gastroenterology. 2000;118(2 Suppl 1):S68-82.
6. M'Koma A E. Inflammatory Bowel Disease: An Expanding Global Health Problem. Clinical Medicine Insights Gastroenterology. 2013(6):33-47.
7. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145(2):293-308.
8. Tremaine WJ. Review article: Indeterminate colitis--definition, diagnosis and management. Aliment Pharmacol Ther. 2007;25(1):13-7.
9. Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13(4-5):463-6.
10. Jevon GP, Madhur R. Endoscopic and histologic findings in pediatric inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6(3):174-80.
11. Nosti PA, Stahl TJ, Sokol AI. Surgical repair of rectovaginal fistulas in patients with Crohn's disease. European journal of obstetrics, gynecology, and reproductive biology. 2013.
12. Nielsen OH, Rogler G, Hahnloser D, Thomsen OO. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol. 2009;6(2):92-106.
13. Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn's disease. Autoimmun Rev. 2014;13(4-5):467-71.
14. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-7.
15. Everhov AH, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Soderling J, et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology. 2018;154(3):518-28 e15.
16. Archampong TN, Nkrumah KN. Inflammatory bowel disease in Accra: what new trends. West Afr J Med. 2013;32(1):40-4.
17. Ukwenya AY, Ahmed A, Odigie VI, Mohammed A. Inflammatory bowel disease in Nigerians: still a rare diagnosis? Ann Afr Med. 2011;10(2):175-9.
18. Agoda-Koussema LK, Anoukoum T, Djibril AM, Balaka A, Folligan K, Adjenou V, et al. [Ulcerative colitis: a case in Togo]. Med Sante Trop. 2012;22(1):79-81.
19. Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, et al. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med. 2012;90(3):252-7.
20. Senbanjo IO, Oshikoya KA, Onyekwere CA, Abdulkareem FB, Njokanma OF. Ulcerative colitis in a Nigerian girl: a case report. BMC Res Notes. 2012;5:564.
21. Bouzid D, Fourati H, Amouri A, Marques I, Abida O, Haddouk S, et al. The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population. Human immunology. 2011;72(12):1204-9.
22. O'Keefe EA, Wright JP, Froggatt J, Cuming L, Elliot M. Medium-term follow-up of ulcerative colitis in Cape Town. S Afr Med J. 1989;76(4):142-5.
23. O'Keefe EA, Wright JP, Froggatt J, Zabow D. Medium-term follow-up of Crohn's disease in Cape Town. S Afr Med J. 1989;76(4):139-41.
24. Segal I. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int J Colorectal Dis. 1988;3(4):222-5.
25. Segal I, Tim LO, Hamilton DG, Walker AR. The rarity of ulcerative colitis in South African blacks. Am J Gastroenterol. 1980;74(4):332-6.
26. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn's disease. S Afr Med J. 1983;63(7):226-9.
27. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. Part I. Ulcerative colitis. S Afr Med J. 1983;63(7):223-6.
28. Brom B, Bank S, Marks IN, Barbezat GO, Raynham B. Crohn's disease in the Cape: a follow-up study of 24 cases and a review of the diagnosis and management. S Afr Med J. 1968;42(41):1099-107.
29. Novis BH, Marks IN, Bank S, Louw JH. Incidence of Crohn's disease at Groote Schuur Hospital during 1970-1974. S Afr Med J. 1975;49(17):693-7.
30. Sobel JD, Schamroth L. Ulcerative colitis in the South African Bantu. Gut. 1970;11(9):760-3.
31. Giraud RM, Luke I, Schmaman A. Crohn's disease in the Transvaal Bantu: a report of 5 cases. S Afr Med J. 1969;43(21):610-3.
32. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, et al. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015;13(6):1197-200.
33. Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-13.
34. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42; quiz e30.
35. Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas JL, Merle V, et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther. 2011;33(10):1133-42.
36. Shmidt E, Dubinsky MC. Inflammatory Bowel Disease and Pregnancy. Am J Gastroenterol. 2022;117(10s):60-8.
37. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol. 1984;6(3):211-6.
38. Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26(4):513-33.
39. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JM, Masson PL, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012;6(8):811-23.
40. Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflammatory bowel diseases. 2011;17(12):2541-50.
41. North American Society for Pediatric Gastroenterology H, Nutrition, Colitis Foundation of A, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44(5):653-74.
42. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18(3):509-23.
43. Wang YR, Loftus EV, Jr., Cangemi JR, Picco MF. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013;88(1):20-5.
44. Afzali A, Cross RK. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases. 2016;22(8):2023-40.
45. Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, et al. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci. 2014;59(2):287-94.
46. Castaneda G, Liu B, Torres S, Bhuket T, Wong RJ. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study. Dig Dis Sci. 2017;62(10):2876-81.
47. Avalos DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, Alvarado A, Dwivedi A, et al. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis. Dig Dis Sci. 2018;63(6):1558-71.
48. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104(8):2100-9.
49. Huang VW, Habal FM. From conception to delivery: managing the pregnant inflammatory bowel disease patient. World J Gastroenterol. 2014;20(13):3495-506.
50. Malhame I, Bublitz MH, Bourjeily G. The Challenge of Screening for Obstructive Sleep Apnea in Pregnancy. Ann Am Thorac Soc. 2019;16(10):1242-4.
51. Balserak BI, Zhu B, Grandner MA, Jackson N, Pien GW. Obstructive sleep apnea in pregnancy: performance of a rapid screening tool. Sleep Breath. 2019;23(2):425-32.
52. Lomakova YD, Chen X, Stein TP, Steer RA. Decreased Adiponectin Levels in Early Pregnancy Are Associated with High Risk of Prematurity for African American Women. Journal of clinical medicine. 2022;11(11).
53. Chen X, Scholl TO, Stein TP, Steer RA, Williams KP. Maternal Circulating Lipid Profile during Early Pregnancy: Racial/Ethnic Differences and Association with Spontaneous Preterm Delivery. Nutrients. 2017;9(1).
54. Manuck TA. Racial and ethnic differences in preterm birth: A complex, multifactorial problem. Semin Perinatol. 2017;41(8):511-8.
55. Huesch M, Doctor JN. Factors associated with increased cesarean risk among African American women: evidence from California, 2010. Am J Public Health. 2015;105(5):956-62.
56. Aron DC, Gordon HS, DiGiuseppe DL, Harper DL, Rosenthal GE. Variations in risk-adjusted cesarean delivery rates according to race and health insurance. Med Care. 2000;38(1):35-44.
57. Sakala C, Belanoff C, Declercq ER. Factors Associated with Unplanned Primary Cesarean Birth: Secondary Analysis of the Listening to Mothers in California Survey. BMC Pregnancy Childbirth. 2020;20(1):462.
58. Hoxha I, Braha M, Syrogiannouli L, Goodman DC, Juni P. Caesarean section in uninsured women in the USA: systematic review and meta-analysis. BMJ Open. 2019;9(3):e025356.
59. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflammatory bowel diseases. 2011;17(7):1573-80.
60. Selinger CP, Ghorayeb J, Madill A. What Factors Might Drive Voluntary Childlessness (VC) in Women with IBD? Does IBD-specific Pregnancy-related Knowledge Matter? J Crohns Colitis. 2016;10(10):1151-8.
61. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflammatory bowel diseases. 2009;15(5):720-5.
62. Elkafrawi D, Sisti G, Araji S, Khoury A, Miller J, Rodriguez Echevarria B. Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption. Medicina (Kaunas). 2020;56(4).
63. Kinser PA, Jallo N, Amstadter AB, Thacker LR, Jones E, Moyer S, et al. Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic. Journal of women's health. 2021;30(5):654-64.
64. Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, et al. Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional Study. J Crohns Colitis. 2018;12(6):702-9.
65. Dove-Medows E, Deriemacker A, Dailey R, Nolan TS, Walker DS, Misra DP, et al. Pregnant African American Women's Perceptions of Neighborhood, Racial Discrimination, and Psychological Distress as Influences on Birth Outcomes. MCN Am J Matern Child Nurs. 2020;45(1):49-56.
66. Zhang M, Wan P, Ng K, Singh K, Cheng TH, Velickovic I, et al. Preeclampsia Among African American Pregnant Women: An Update on Prevalence, Complications, Etiology, and Biomarkers. Obstet Gynecol Surv. 2020;75(2):111-20.
67. Mileski MR, Shirey MR, Patrician PA, Childs G. Perceived Racial Discrimination in the Pregnant African American Population: A Concept Analysis. ANS Adv Nurs Sci. 2021;44(4):306-16.
68. Pinder M, Lummis K, Selinger CP. Managing inflammatory bowel disease in pregnancy: current perspectives. Clinical and experimental gastroenterology. 2016;9:325-35.
69. Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M. State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. Inflammatory bowel diseases. 2016;22(7):1609-15.
70. Mahadevan U. How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities. Gastroenterology. 2017;152(8):1813-6.
71. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019;156(5):1508-24.
72. Herman AM HA, James SD3, Ballard BR, M'Koma AE. Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations. Japanise Journal of Gastroenterology and Hepatology. 2020;3(2):1-11.
73. Body C, Christie JA. Gastrointestinal Diseases in Pregnancy: Nausea, Vomiting, Hyperemesis Gravidarum, Gastroesophageal Reflux Disease, Constipation, and Diarrhea. Gastroenterol Clin North Am. 2016;45(2):267-83.
74. Passi M MC, Marie B. P-090 African-American Women with Inflammatory Bowel Disease Deliver More Low Birth Weight Infants than White Women. Inflammatory Bowel Diseases 2014(1):S63-S4.
75. Johnson JE, Roman L, Key KD, Meulen MV, Raffo JE, Luo Z, et al. Study protocol: The Maternal Health Multilevel Intervention for Racial Equity (Maternal Health MIRACLE) Project. Contemp Clin Trials. 2022;120:106894.
76. Alio AP, Dillion T, Hartman S, Johnson T, Turner S, Bullock S, et al. A Community Collaborative for the Exploration of Local Factors Affecting Black Mothers' Experiences with Perinatal Care. Matern Child Health J. 2022;26(4):751-60.
77. Gillespie SL, Christian LM, Mackos AR, Nolan TS, Gondwe KW, Anderson CM, et al. Lifetime stressor exposure, systemic inflammation during pregnancy, and preterm birth among Black American women. Brain Behav Immun. 2022;101:266-74.
78. Suresh S, Amegashie C, Patel E, Nieman KM, Rana S. Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia. Curr Hypertens Rep. 2022;24(4):87-93.
79. Cochrane KM, Hutcheon JA, Karakochuk CD. Iron-Deficiency Prevalence and Supplementation Practices Among Pregnant Women: A Secondary Data Analysis From a Clinical Trial in Vancouver, Canada. J Nutr. 2022;152(10):2238-44.
80. Jun S, Gahche JJ, Potischman N, Dwyer JT, Guenther PM, Sauder KA, et al. Dietary Supplement Use and Its Micronutrient Contribution During Pregnancy and Lactation in the United States. Obstet Gynecol. 2020;135(3):623-33.
81. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106.
82. Herfarth HH, Kappelman MD, Long MD, Isaacs KL. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases. Inflammatory bowel diseases. 2016;22(1):224-33.
83. Dignass AU, Gasche C, Bettenworth D, Birgegard G, Danese S, Gisbert JP, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-22.
84. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58(2):229-37.
85. Sahyoun LC, Gaidos JKJ. A Practical Approach to IBD Care in the Pregnant Patient. Curr Gastroenterol Rep. 2022.
86. Vieujean S, De Vos M, Paridaens K, Daftary GS, Danese S, Peyrin-Biroulet L. Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: a systematic review. J Crohns Colitis. 2022.
87. Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, et al. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. J Crohns Colitis. 2022.
88. Manosa M, Navarro-Llavat M, Marin L, Zabana Y, Cabre E, Domenech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol. 2013;48(4):427-32.
89. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut. 1984;25(1):52-6.
90. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut. 1980;21(6):469-74.
91. Lindhagen T, Bohe M, Ekelund G, Valentin L. Fertility and outcome of pregnancy in patients operated on for Crohn's disease. Int J Colorectal Dis. 1986;1(1):25-7.
92. De Dombal FT, Burton IL, Goligher JC. Crohn's disease and pregnancy. Br Med J. 1972;3(5826):550-3.
93. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut. 1986;27(7):821-5.
94. Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorectal Dis. 1997;12(4):220-4.
95. Arkuran C, McComb P. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol. 2000;27(1):12-3.
96. M'Koma AE. Observation on essential biochemical data profile in connection with restorative proctocolectomy in humans. Vitamin B12 and fat absorption cited. Dissertation Thesis. 2001:1-126.
97. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55(11):1575-80.
98. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56(6):830-7.
99. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS. Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis. 2011;26(11):1365-74.
100. Tulchinsky H, Averboukh F, Horowitz N, Rabau M, Klausner JM, Halpern Z, et al. Restorative proctocolectomy impairs fertility and pregnancy outcomes in women with ulcerative colitis. Colorectal Dis. 2013;15(7):842-7.
101. Hull TL, Joyce MR, Geisler DP, Coffey JC. Adhesions after laparoscopic and open ileal pouch-anal anastomosis surgery for ulcerative colitis. Br J Surg. 2012;99(2):270-5.
102. Beyer-Berjot L, Maggiori L, Birnbaum D, Lefevre JH, Berdah S, Panis Y. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg. 2013;258(2):275-82.
103. Bartels SA, D'Hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256(6):1045-8.
104. Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):847-53.
105. Vieujean S, De Vos M, D'Amico F, Paridaens K, Daftary G, Dudkowiak R, et al. Inflammatory bowel disease meets fertility: A physician and patient survey. Dig Liver Dis. 2023.
106. Huang VW, Chang HJ, Kroeker KI, Goodman KJ, Hegadoren KM, Dieleman LA, et al. Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? Can J Gastroenterol Hepatol. 2015;29(2):95-103.
107. Hardeman RR, Karbeah J, Kozhimannil KB. Applying a critical race lens to relationship-centered care in pregnancy and childbirth: An antidote to structural racism. Birth. 2020;47(1):3-7.
108. Hardeman RR, Karbeah J. Examining racism in health services research: A disciplinary self-critique. Health Serv Res. 2020;55 Suppl 2(Suppl 2):777-80.
109. Jones CP. Levels of racism: a theoretic framework and a gardener's tale. Am J Public Health. 2000;90(8):1212-5.
110. Williams DR, Sternthal M. Understanding racial-ethnic disparities in health: sociological contributions. J Health Soc Behav. 2010;51 Suppl(Suppl):S15-27.
111. Cushing L, Faust J, August LM, Cendak R, Wieland W, Alexeeff G. Racial/Ethnic Disparities in Cumulative Environmental Health Impacts in California: Evidence From a Statewide Environmental Justice Screening Tool (CalEnviroScreen 1.1). Am J Public Health. 2015;105(11):2341-8.
112. Moriya AS, Chakravarty S. Racial And Ethnic Disparities In Preventable Hospitalizations And ED Visits Five Years After ACA Medicaid Expansions. Health affairs. 2023;42(1):26-34.
113. Braveman PA AE, Proctor D, Kauh T, Holm N. Systemic And Structural Racism:Definitions, Examples, HealthDamages, and Approaches To Dismantling. Health affairs. 2022;41(2):171-8.
114. Kauh TJ, Read JG, Scheitler AJ. The Critical Role of Racial/Ethnic Data Disaggregation for Health Equity. Popul Res Policy Rev. 2021;40(1):1-7.
115. Bailey ZD, Krieger N, Agenor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-63.
116. Camara P, Jones. Confronting Institutionalized Racism: Clark Atlanta University; 2002.
117. Chirwa S, Nwabuisi CR, Ladson GM, Korley L, Whitty JE, Atkinson R, et al. Poor Sleep Quality Is Associated with Higher Hemoglobin A1c in Pregnant Women: A Pilot Observational Study. International journal of environmental research and public health. 2018;15(10).
118. Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11(8):965-71.
119. Sobolewska-Wlodarczyk A, Wlodarczyk M, Banasik J, Gasiorowska A, Wisniewska-Jarosinska M, Fichna J. Sleep disturbance and disease activity in adult patients with inflammatory bowel diseases. J Physiol Pharmacol. 2018;69(3).
120. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22(11):1748-53.
121. Vedamurthy A, Ananthakrishnan AN. Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019;15(2):72-82.
122. Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflammatory bowel diseases. 2019;25(5):843-52.
123. Francis B, Klebanoff M, Oza-Frank R. Racial discrimination and perinatal sleep quality. Sleep Health. 2017;3(4):300-5.
124. Cohen MF, Corwin EJ, Johnson DA, Amore AD, Brown AL, Barbee NR, et al. Discrimination is associated with poor sleep quality in pregnant Black American women. Sleep Med. 2022;100:39-48.
125. Alhalel J, Patterson L, Francone NO, Danner S, Osei C, O'Brian CA, et al. Addressing racial disparities in perinatal care for African American/Black individuals in the Chicago community health setting: a qualitative study. BMC Pregnancy Childbirth. 2022;22(1):771.
126. Marinelli C, Savarino EV, Marsilio I, Lorenzon G, Gavaruzzi T, D'Inca R, et al. Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study. Sci Rep. 2020;10(1):507.
127. Nassikas N, Malhame I, Miller M, Bourjeily G. Pulmonary Considerations for Pregnant Women. Clin Chest Med. 2021;42(3):483-96.
128. Holdcroft A, Bevan DR, O'Sullivan JC, Sykes MK. Airway closure and pregnancy. Anaesthesia. 1977;32(6):517-23.
129. Middleton PG. Obstructive sleep apnoea and sleep disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2022;85(Pt A):107-13.
130. Brown NT, Turner JM, Kumar S. The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol. 2018;219(2):147-61 e1.
131. Oyiengo D, Louis M, Hott B, Bourjeily G. Sleep disorders in pregnancy. Clin Chest Med. 2014;35(3):571-87.
132. Franklin KA, Holmgren PA, Jonsson F, Poromaa N, Stenlund H, Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest. 2000;117(1):137-41.
133. O'Brien LM, Bullough AS, Chames MC, Shelgikar AV, Armitage R, Guilleminualt C, et al. Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG : an international journal of obstetrics and gynaecology. 2014;121(13):1685-93.
134. Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med. 2000;162(1):252-7.
135. Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep. 2004;27(1):79-84.
136. Pilkington S, Carli F, Dakin MJ, Romney M, De Witt KA, Dore CJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74(6):638-42.
137. Sedov ID, Cameron EE, Madigan S, Tomfohr-Madsen LM. Sleep quality during pregnancy: A meta-analysis. Sleep Med Rev. 2018;38:168-76.
138. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-5.
139. Blyton DM, Skilton MR, Edwards N, Hennessy A, Celermajer DS, Sullivan CE. Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep. 2013;36(1):15-21.
140. Garbazza C, Hackethal S, Riccardi S, Cajochen C, Cicolin A, D'Agostino A, et al. Polysomnographic features of pregnancy: A systematic review. Sleep Med Rev. 2020;50:101249.
141. Carvalho KM, Figueiredo M, Galindo Neto NM, Sa GGM, Silva C, Mendes PN. Comparison of the effectiveness of two educational interventions on sleep quality in older adults: a randomized clinical trial. Rev Esc Enferm USP. 2022;56:e20220326.
142. Singh AH, Bathla M, Gupta P, Bhusri L. Quality of sleep and disability associated with headache: migraine versus tension-type headache: A comparative study. Ann Afr Med. 2023;22(1):11-7.
143. Sweeney BM, Signal TL, Babbage DR. Effect of a behavioral-educational sleep intervention for first-time mothers and their infants: pilot of a controlled trial. J Clin Sleep Med. 2020;16(8):1265-74.
144. Ladyman C, Gander P, Huthwaite M, Sweeney B, Signal TL. Sleep HAPi: A Feasibility and Descriptive Analysis of an Early and Longitudinal Sleep Education Intervention for Pregnant Women. Behav Sleep Med. 2021;19(4):427-44.
145. Gessesse DN, Tsega NT, Aklil MB, Temesgan WZ, Abegaz MY, Anteneh TA, et al. Prevalence and associated factors of poor sleep quality among postpartum women in North West Ethiopia: a community-based study. BMC Psychiatry. 2022;22(1):538.
146. Lucchini M, O'Brien LM, Kahn LG, Brennan PA, Glazer Baron K, Knapp EA, et al. Racial/ethnic disparities in subjective sleep duration, sleep quality, and sleep disturbances during pregnancy: an ECHO study. Sleep. 2022;45(9).
147. Felix NAR, Ceolim MF. Sleep in pregnancy quarters: a longitudinal study. Rev Gaucha Enferm. 2022;44:e20210278.
148. Cai YM, Zheng XL, Shen ZM, Zhou BF, Liu YM, Yang JY, et al. Study on the sleep quality of women pregnant with a second child and the influencing factors. Eur J Med Res. 2022;27(1):207.
149. Wirth MD, Liu J, Wallace MK, McLain AC, Turner-McGrievy GM, Davis JE, et al. Dietary Inflammatory Index and sleep quality and duration among pregnant women with overweight or obesity. Sleep. 2022;45(12).
150. Lau Y, Cheng LJ, Chee DGH, Zhao M, Wong SH, Wong SN, et al. High body mass index and sleep problems during pregnancy: A meta-analysis and meta-regression of observational studies. J Sleep Res. 2022;31(1):e13443.
151. Ghante A, Raj JP, Krishna B, Thomas A. Prevalence and predictors of sleep deprivation and poor sleep quality and their associated perinatal outcomes during the third trimester of pregnancy. J Taibah Univ Med Sci. 2021;16(3):359-64.
152. Cao V, Makarem N, Maguire M, Samayoa I, Xi H, Liang C, et al. History of Weight Cycling Is Prospectively Associated With Shorter and Poorer-Quality Sleep and Higher Sleep Apnea Risk in Diverse US Women. J Cardiovasc Nurs. 2021;36(6):573-81.
153. Papadopoulou SK, Mantzorou M, Voulgaridou G, Pavlidou E, Vadikolias K, Antasouras G, et al. Nutritional Status Is Associated with Health-Related Quality of Life, Physical Activity, and Sleep Quality: A Cross-Sectional Study in an Elderly Greek Population. Nutrients. 2023;15(2).
154. Bei B, Pinnington DM, Shen L, Blumfield M, Drummond SPA, Newman LK, et al. A scalable cognitive behavioural program to promote healthy sleep during pregnancy and postpartum periods: protocol of a randomised controlled trial (the SEED project). BMC Pregnancy Childbirth. 2019;19(1):254.
155. Rezaei E, Moghadam ZB, Nejat S, Dehghannayeri N. The impact of sleep healthy behavior education on the quality of life in the pregnant women with sleep disorder: A randomized control trial in the year 2012. Iran J Nurs Midwifery Res. 2014;19(5):508-16.
156. Hayase M, Shimada M, Seki H. Sleep quality and stress in women with pregnancy-induced hypertension and gestational diabetes mellitus. Women Birth. 2014;27(3):190-5.
157. Umeno S, Kato C, Nagaura Y, Kondo H, Eto H. Characteristics of sleep/wake problems and delivery outcomes among pregnant Japanese women without gestational complications. BMC Pregnancy Childbirth. 2020;20(1):179.
158. Felder JN, Roubinov D, Zhang L, Gray M, Beck A. Endorsement of a single-item measure of sleep disturbance during pregnancy and risk for postpartum depression: a retrospective cohort study. Arch Womens Ment Health. 2023.
159. Baattaiah BA, Alharbi MD, Babteen NM, Al-Maqbool HM, Babgi FA, Albatati AA. The relationship between fatigue, sleep quality, resilience, and the risk of postpartum depression: an emphasis on maternal mental health. BMC Psychol. 2023;11(1):10.
160. Brekke M, Amro A, Smastuen MC, Glavin K, Solberg B, Oygarden AU, et al. Quality of life in Norwegian pregnant women and men with pregnant partners, and association with perception of sleep and depressive symptoms: a cross-sectional study. BMC Pregnancy Childbirth. 2023;23(1):37.
161. Vanderlinden J, Boen F, van Uffelen JGZ. Effects of physical activity programs on sleep outcomes in older adults: a systematic review. Int J Behav Nutr Phys Act. 2020;17(1):11.
162. Das S, Roy RN, Das DK, Chakraborty A, Mondal R. Sleep Quality and its various correlates: A community-based study among geriatric population in a community development block of Purba Bardhaman district, West Bengal. J Family Med Prim Care. 2020;9(3):1510-6.
163. Ngui EM, Warner TD, Roberts LW. Perceptions of African-American health professionals and community members on the participation of children and pregnant women in genetic research. Public Health Genomics. 2014;17(1):23-32.
164. Thomas SB, Fine MJ, Ibrahim SA. Health disparities: the importance of culture and health communication. Am J Public Health. 2004;94(12):2050.
165. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295-309.
166. Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV, Jr. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol. 2019;12:1756284819827692.
167. Misra R, Faiz O, Munkholm P, Burisch J, Arebi N. Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups. World J Gastroenterol. 2018;24(3):424-37.
168. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012-23.
169. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflammatory bowel diseases. 2007;13(12):1529-35.
170. Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105(10):2202-8.
171. Nguyen GC, Bouchard S, Diong C, Promoting A, Care through Centres of Excellence N. Access to Specialists and Emergency Department Visits in Inflammatory Bowel Disease: A Population-Based Study. J Crohns Colitis. 2019;13(3):330-6.
172. Habal FM, Huang VW. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther. 2012;35(5):501-15.
173. Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med. 2020;13(2):62-9.
174. Evans LM, Myers MM, Monk C. Pregnant women's cortisol is elevated with anxiety and depression - but only when comorbid. Arch Womens Ment Health. 2008;11(3):239-48.
175. Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther. 2011;34(7):724-34.
176. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102(9):1947-54.
177. Hatch Q, Champagne BJ, Maykel JA, Davis BR, Johnson EK, Bleier JS, et al. Crohn's disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum. 2014;57(2):174-8.
178. van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9(2):107-24.
179. Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther. 2011;34(2):125-45.
180. Schulze H, Esters P, Dignass A. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation. Aliment Pharmacol Ther. 2014;40(9):991-1008.
181. Tremblay E, Therasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics. 2012;32(3):897-911.
182. Haq AI, Sahai A, Hallwoth S, Rampton DS, Dorudi S. Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature. Int J Colorectal Dis. 2006;21(5):465-9.
183. Overbey D, Govekar H, Gajdos C. Surgical management of colonic perforation due to ulcerative colitis during pregnancy: Report of a case. World journal of gastrointestinal surgery. 2014;6(10):201-3.
184. Naganuma M, Kunisaki R, Yoshimura N, Nagahori M, Yamamoto H, Kimura H, et al. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. J Crohns Colitis. 2011;5(4):317-23.
185. Nielsen OH, Gubatan JM, Juhl CB, Streett SE, Maxwell C. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(1):74-87 e3.
186. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Am J Obstet Gynecol. 2019;220(4):308-23.
187. Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(5):460-6.
188. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387-411.
189. Ronchetti C, Cirillo F, Di Segni N, Cristodoro M, Busnelli A, Levi-Setti PE. Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review. Nutrients. 2022;14(8).
190. Seifarth C, Ritz JP, Pohlen U, Kroesen AJ, Siegmund B, Frericks B, et al. Therapy of complicated Crohn's disease during pregnancy--an interdisciplinary challenge. Int J Colorectal Dis. 2014;29(6):645-51.
191. Walldorf J, Zwirnmann K, Seufferlein T. [Pregnancy and inflammatory bowel disease]. Internist (Berl). 2011;52(1):76, 8-80.
192. van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, et al. Modulation of cytokine patterns and microbiome during pregnancy in IBD. Gut. 2020;69(3):473-86.
193. Kim ES, Tarassishin L, Eisele C, Barre A, Nair N, Rendon A, et al. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies. Gastroenterology. 2021;160(4):1118-30 e3.
194. Toomey D, Waldron B. Family planning and inflammatory bowel disease: the patient and the practitioner. Fam Pract. 2013;30(1):64-8.
195. Walldorf J, Pijan E, Greinert R, Riesner-Wehner A, Michl P. Family planning with inflammatory bowel disease: the challenge of childlessness and parent concerns. Z Gastroenterol. 2021;59(8):841-50.
196. Flanagan E, Wright EK, Sparrow MP, Moore GT, Connell WR, De Cruz P, et al. A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflammatory bowel diseases. 2021;27(12):1909-18.
197. Tsuda S, Sameshima A, Sekine M, Kawaguchi H, Fujita D, Makino S, et al. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. Mod Rheumatol. 2020;30(5):852-61.
198. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer L. Disease-related pregnancy concerns and reproductive planning in women with inflammatory bowel diseases. J Fam Plann Reprod Health Care. 2015;41(4):272-7.
199. Gawron LM, Hammond C, Keefer L. Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases. Patient Educ Couns. 2014;94(1):134-7.
200. Steinlauf AF, Present DH. Medical management of the pregnant patient with inflammatory bowel disease. Gastroenterol Clin North Am. 2004;33(2):361-85, xi.
201. Dos Santos Marques IC, Theiss LM, Baker SJ, Liwo A, Wood LN, Cannon JA, et al. Low Health Literacy Exists in the Inflammatory Bowel Disease (IBD) Population and Is Disproportionately Prevalent in Older African Americans. Crohns Colitis 360. 2020;2(4).
202. Dos Santos Marques IC, Herbey, II, Theiss LM, Shao CC, Fouad MN, Scarinci IC, et al. Understanding the surgical experience for Black and White patients with inflammatory bowel disease (IBD): The importance of health literacy. Am J Surg. 2022;223(2):303-11.
203. Kaps L, Omogbehin L, Hildebrand K, Gairing SJ, Schleicher EM, Moehler M, et al. Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer. Sci Rep. 2022;12(1):21072.
204. Mehra R, Alspaugh A, Dunn JT, Franck LS, McLemore MR, Keene DE, et al. "'Oh gosh, why go?' cause they are going to look at me and not hire": intersectional experiences of black women navigating employment during pregnancy and parenting. BMC Pregnancy Childbirth. 2023;23(1):17.
205. Liese K, Stewart K, Pearson P, Lofton S, Mbande T, Patil C, et al. Melanated Group Midwifery Care: Centering the Voices of the Black Birthing Community. J Midwifery Womens Health. 2022;67(6):696-700.
206. Chaparro M, Donday MG, Abad-Santos F, Martin de Carpi FJ, Macia-Martinez MA, Montero D, et al. The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU. Therap Adv Gastroenterol. 2021;14:17562848211018097.
207. Laube R, Paramsothy S, Leong RW. Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis. Expert Opin Drug Saf. 2021;20(3):275-92.
208. Gubatan J, Nielsen OH, Levitte S, Juhl CB, Maxwell C, Streett SE, et al. Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2021;116(2):243-53.
209. Pedersen N, Bortoli A, Duricova D, R DI, Panelli MR, Gisbert JP, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38(5):501-12.
210. de Lima A, Zelinkova Z, Mulders AG, van der Woude CJ. Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy. Clin Gastroenterol Hepatol. 2016;14(9):1285-92 e1.
211. Friedman SH, Heneghan A, Rosenthal M. Characteristics of women who do not seek prenatal care and implications for prevention. J Obstet Gynecol Neonatal Nurs. 2009;38(2):174-81.
212. Clark EC, Cranston E, Polin T, Ndumbe-Eyoh S, MacDonald D, Betker C, et al. Structural interventions that affect racial inequities and their impact on population health outcomes: a systematic review. BMC Public Health. 2022;22(1):2162.
213. Jeffers NK, Berger BO, Marea CX, Gemmill A. Investigating the impact of structural racism on black birthing people - associations between racialized economic segregation, incarceration inequality, and severe maternal morbidity. Soc Sci Med. 2023;317:115622.
214. OjiNjideka Hemphill N, Crooks N, Zhang W, Fitter F, Erbe K, Rutherford JN, et al. Obstetric experiences of young black mothers: An intersectional perspective. Soc Sci Med. 2023;317:115604.
215. Gao X, Snowden JM, Tucker CM, Allen A, Morello-Frosch R, Abrams B, et al. Remapping racial and ethnic inequities in severe maternal morbidity: The legacy of redlining in California. Paediatr Perinat Epidemiol. 2022.
216. Maternal, Child Nutrition Study G, Group m, Black RE, Alderman H, Bhutta ZA, et al. Maternal and child nutrition: building momentum for impact. Lancet. 2013;382(9890):372-5.
217. Plaza-Diaz J, Ruiz-Ojeda FJ, Morales J, de la Torre AIC, Garcia-Garcia A, de Prado CN, et al. Effects of a Novel Infant Formula on Weight Gain, Body Composition, Safety and Tolerability to Infants: The INNOVA 2020 Study. Nutrients. 2022;15(1).
218. Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics. 2003;112(3 Pt 1):e177-83.
219. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4 Suppl 1:S17-30.
220. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflammatory bowel diseases. 2019;25(4):627-41.
221. Kokoszko-Bilska A, Sobkiewicz S, Fichna J. Inflammatory bowel diseases and reproductive health. Pharmacol Rep. 2016;68(4):859-64.
222. Selinger CP, Leong RW, Lal S. Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective. World J Gastroenterol. 2012;18(21):2600-8.
223. Maliszewska AM, Warska A, Cendrowski K, Sawicki W. Inflammatory bowel disease and pregnancy. Ginekol Pol. 2017;88(7):398-403.
224. Ellul P, Zammita SC, Katsanos KH, Cesarini M, Allocca M, Danese S, et al. Perception of Reproductive Health in Women with Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(8):886-91.
225. Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, et al. Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy. Patient. 2022;15(3):353-65.
226. Long MD, Siegel CA, Abraham BP, Chiorean M, Mahadevan U. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022;20(3):706-8 e1.
227. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, et al. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology. 2021;160(4):1131-9.
228. Bengtson MB, Aamodt G, Mahadevan U, Vatn MH. Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study. Inflammatory bowel diseases. 2017;23(7):1225-33.
229. Bengtson MB, Haugen M, Brantsaeter AL, Aamodt G, Vatn MH. Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort. BMC Gastroenterol. 2020;20(1):28.
230. Myklebust-Hansen T, Aamodt G, Haugen M, Brantsaeter AL, Vatn MH, Bengtson MB. Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa). Inflammatory bowel diseases. 2017;24(1):12-24.
231. Picardo S, Seow CH. A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy. Drugs. 2019;79(10):1053-63.
232. Horst S, Kane S. The use of biologic agents in pregnancy and breastfeeding. Gastroenterol Clin North Am. 2014;43(3):495-508.
233. Wang H, Hu Y, Chen F, Shen M. Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. BMC Pregnancy Childbirth. 2022;22(1):854.
234. Clowse M, Fischer-Betz R, Nelson-Piercy C, Scheuerle AE, Stephan B, Dubinsky M, et al. Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol. Ther Adv Musculoskelet Dis. 2022;14:1759720X221087650.
235. Wiersma TK, Visschedijk MC, de Boer NK, Lub-de Hooge MN, Prins JR, Touw DJ, et al. The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review. Pharmaceutics. 2022;14(6).
236. Wieringa JW, Driessen GJ, Van Der Woude CJ. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Expert Rev Gastroenterol Hepatol. 2018;12(8):811-8.
237. Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. Gastroenterology. 2018;155(3):696-704.
238. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018;16(1):99-105.
239. Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, et al. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. Gastroenterology. 2016;151(1):110-9.
240. Weiss B, Ben-Horin S, Lev A, Broide E, Yavzori M, Lahat A, et al. Immune function in newborns with in-utero exposure to anti-TNFalpha therapy. Front Pediatr. 2022;10:935034.
241. de Aragao MC, Beraldo RF, Marcondes MB, de Barros JR, Herrerias GSP, Saad-Hossne R, et al. Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review. Medicine (Baltimore). 2021;100(51):e28274.
242. Sako M, Yoshimura N, Sonoda A, Okano S, Ueda M, Tezuka M, et al. Safety Prediction of Infants Born to Mothers with Crohn's Disease Treated with Biological Agents in the Late Gestation Period. J Anus Rectum Colon. 2021;5(4):426-32.
243. Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology. 2016;150(3):734-57 e1.
244. Burke KE, Haviland MJ, Hacker MR, Shainker SA, Cheifetz AS. Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2017;23(5):721-6.
245. Foulon A, Dupas JL, Sabbagh C, Chevreau J, Rebibo L, Brazier F, et al. Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review. Inflammatory bowel diseases. 2017;23(5):712-20.
246. Brestfeeding So. Breast feeding anf thevuse of human milk. Pediatrics. 2012;129:e827-e41.
247. Brodribb W. ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018. Breastfeed Med. 2018;13(5):307-14.
248. Anderson PO. Drugs that Suppress Lactation, Part 2. Breastfeed Med. 2017;12:199-201.
249. Sezgin E, Terlemez G, Bozkurt B, Bengi G, Akpinar H, Buyuktorun I. Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. PeerJ. 2022;10:e14217.
250. Godny L, Svolos V, Williams AJ, Czuber-Dochan W, Aloi M, Ibarra A, et al. Multidisciplinary Perinatal Care in IBD. J Crohns Colitis. 2022.
251. Selinger CP, Nelson-Piercy C, Fraser A, Hall V, Limdi J, Smith L, et al. IBD in pregnancy: recent advances, practical management. Frontline Gastroenterol. 2021;12(3):214-24.
252. Feng Z, Kang G, Wang J, Gao X, Wang X, Ye Y, et al. Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023;158:114174.
253. AE MK. Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management. Medical Research Archives. 2023;11(1).
254. Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, et al. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(3):215-27.
255. Danese S, Vermeire S, D'Haens G, Panes J, Dignass A, Magro F, et al. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. Lancet Gastroenterol Hepatol. 2022;7(4):294-306.
256. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022;58(5).
257. M'Koma AE. Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis. 2006;21(7):711-20.
258. M'Koma AE, Wise PE, Muldoon RL, Schwartz DA, Washington MK, Herline AJ. Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones. Int J Colorectal Dis. 2007;22(10):1143-63.
259. M'Koma AE, Lindquist K, Liljeqvist L. Biochemical laboratory data in patients before and after restorative proctocolectomy. A study on 83 patients with a follow-up of 36 months. Ann Chir. 1994;48(6):525-34.
260. M'Koma AE, Lindquist K, Liljeqvist L. Effect of restorative proctocolectomy on gastric acid secretion and serum gastrin levels: a prospective study. Dis Colon Rectum. 1999;42(3):398-402.
261. Ballard BR, M'Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis. World journal of gastrointestinal endoscopy. 2015;7(7):670-4.
262. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, et al. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PloS one. 2017;12(8):e0179710.
263. M'Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World journal of gastrointestinal surgery. 2014;6(11):208-19.
264. Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, et al. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PloS one. 2021;16(3):e0246393.
265. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001;2(4):463-71.
266. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Jama. 1999;282(11):1054-60.
267. Tandon P, Natt N, Malhi G, Wong EC, Matthews P, Reinisch W, et al. Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis. Eur J Gastroenterol Hepatol. 2023;35(3):231-40.
268. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
269. Darie AM, Sinopoulou V, Ajay V, Bel Kok K, Patel KV, Limdi J, et al. BSG 2024 IBD guidelines protocol (standard operating procedures). BMJ Open Gastroenterol. 2023;10(1).
270. Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11(6):649-70.
271. Leenhardt R, Riviere P, Papazian P, Nion-Larmurier I, Girard G, Laharie D, et al. Sexual health and fertility for individuals with inflammatory bowel disease. World J Gastroenterol. 2019;25(36):5423-33.
272. Lee S, Crowe M, Seow CH, Kotze PG, Kaplan GG, Metcalfe A, et al. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database Syst Rev. 2019;7(7):CD012711.
273. Goto Y, Uchino M, Horio Y, Kusunoki K, Minagawa T, Kuwahara R, et al. Delivery Mode after Ileal Pouch-Anal Anastomosis among Pregnant Women with Ulcerative Colitis. J Anus Rectum Colon. 2021;5(4):419-25.
274. Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg. 2007;94(4):478-82.
275. Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47(7):1127-35.
276. Anderson BT, Ertle JT, Borum ML. Men with inflammatory bowel disease are rarely counseled regarding effects of immunosuppressive therapy on fertility and pregnancy. J Crohns Colitis. 2013;7(12):e716.
277. Roy A CC, Martin C, Kane SV, Dubinsky M, Sandborn WJ, Sands BE, Mahdevan U. Exposure to Biologic Therapy and Childhood Development among Offspring of Women with Inflammatory Bowel Disease: Results from the Piano Registry. Gastroenterology. 2017;152(5):S85-S6.
278. Khil J, Picardo S, Seow CH, Leung Y, Metcalfe A, Afshar EE, et al. Physiological and psychological stress in pregnant women with quiescent inflammatory bowel disease: A pilot study using salivary biomarkers. JGH Open. 2020;4(4):692-7.
279. Mikocka-Walus A, Pittet V, Rossel JB, von Kanel R, Swiss IBDCSG. Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016;14(6):829-35 e1.
2. Siegmund B, Zeitz M. [Inflammatory bowel disease and pregnancy]. Z Gastroenterol. 2009;47(10):1069-74.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417-29.
4. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14(1):15-9.
5. Sands BE. Therapy of inflammatory bowel disease. Gastroenterology. 2000;118(2 Suppl 1):S68-82.
6. M'Koma A E. Inflammatory Bowel Disease: An Expanding Global Health Problem. Clinical Medicine Insights Gastroenterology. 2013(6):33-47.
7. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145(2):293-308.
8. Tremaine WJ. Review article: Indeterminate colitis--definition, diagnosis and management. Aliment Pharmacol Ther. 2007;25(1):13-7.
9. Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13(4-5):463-6.
10. Jevon GP, Madhur R. Endoscopic and histologic findings in pediatric inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6(3):174-80.
11. Nosti PA, Stahl TJ, Sokol AI. Surgical repair of rectovaginal fistulas in patients with Crohn's disease. European journal of obstetrics, gynecology, and reproductive biology. 2013.
12. Nielsen OH, Rogler G, Hahnloser D, Thomsen OO. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol. 2009;6(2):92-106.
13. Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn's disease. Autoimmun Rev. 2014;13(4-5):467-71.
14. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-7.
15. Everhov AH, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Soderling J, et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology. 2018;154(3):518-28 e15.
16. Archampong TN, Nkrumah KN. Inflammatory bowel disease in Accra: what new trends. West Afr J Med. 2013;32(1):40-4.
17. Ukwenya AY, Ahmed A, Odigie VI, Mohammed A. Inflammatory bowel disease in Nigerians: still a rare diagnosis? Ann Afr Med. 2011;10(2):175-9.
18. Agoda-Koussema LK, Anoukoum T, Djibril AM, Balaka A, Folligan K, Adjenou V, et al. [Ulcerative colitis: a case in Togo]. Med Sante Trop. 2012;22(1):79-81.
19. Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, et al. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med. 2012;90(3):252-7.
20. Senbanjo IO, Oshikoya KA, Onyekwere CA, Abdulkareem FB, Njokanma OF. Ulcerative colitis in a Nigerian girl: a case report. BMC Res Notes. 2012;5:564.
21. Bouzid D, Fourati H, Amouri A, Marques I, Abida O, Haddouk S, et al. The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population. Human immunology. 2011;72(12):1204-9.
22. O'Keefe EA, Wright JP, Froggatt J, Cuming L, Elliot M. Medium-term follow-up of ulcerative colitis in Cape Town. S Afr Med J. 1989;76(4):142-5.
23. O'Keefe EA, Wright JP, Froggatt J, Zabow D. Medium-term follow-up of Crohn's disease in Cape Town. S Afr Med J. 1989;76(4):139-41.
24. Segal I. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int J Colorectal Dis. 1988;3(4):222-5.
25. Segal I, Tim LO, Hamilton DG, Walker AR. The rarity of ulcerative colitis in South African blacks. Am J Gastroenterol. 1980;74(4):332-6.
26. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn's disease. S Afr Med J. 1983;63(7):226-9.
27. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. Part I. Ulcerative colitis. S Afr Med J. 1983;63(7):223-6.
28. Brom B, Bank S, Marks IN, Barbezat GO, Raynham B. Crohn's disease in the Cape: a follow-up study of 24 cases and a review of the diagnosis and management. S Afr Med J. 1968;42(41):1099-107.
29. Novis BH, Marks IN, Bank S, Louw JH. Incidence of Crohn's disease at Groote Schuur Hospital during 1970-1974. S Afr Med J. 1975;49(17):693-7.
30. Sobel JD, Schamroth L. Ulcerative colitis in the South African Bantu. Gut. 1970;11(9):760-3.
31. Giraud RM, Luke I, Schmaman A. Crohn's disease in the Transvaal Bantu: a report of 5 cases. S Afr Med J. 1969;43(21):610-3.
32. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, et al. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015;13(6):1197-200.
33. Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-13.
34. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42; quiz e30.
35. Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas JL, Merle V, et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther. 2011;33(10):1133-42.
36. Shmidt E, Dubinsky MC. Inflammatory Bowel Disease and Pregnancy. Am J Gastroenterol. 2022;117(10s):60-8.
37. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol. 1984;6(3):211-6.
38. Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26(4):513-33.
39. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JM, Masson PL, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012;6(8):811-23.
40. Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflammatory bowel diseases. 2011;17(12):2541-50.
41. North American Society for Pediatric Gastroenterology H, Nutrition, Colitis Foundation of A, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44(5):653-74.
42. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18(3):509-23.
43. Wang YR, Loftus EV, Jr., Cangemi JR, Picco MF. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013;88(1):20-5.
44. Afzali A, Cross RK. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases. 2016;22(8):2023-40.
45. Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, et al. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci. 2014;59(2):287-94.
46. Castaneda G, Liu B, Torres S, Bhuket T, Wong RJ. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study. Dig Dis Sci. 2017;62(10):2876-81.
47. Avalos DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, Alvarado A, Dwivedi A, et al. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis. Dig Dis Sci. 2018;63(6):1558-71.
48. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104(8):2100-9.
49. Huang VW, Habal FM. From conception to delivery: managing the pregnant inflammatory bowel disease patient. World J Gastroenterol. 2014;20(13):3495-506.
50. Malhame I, Bublitz MH, Bourjeily G. The Challenge of Screening for Obstructive Sleep Apnea in Pregnancy. Ann Am Thorac Soc. 2019;16(10):1242-4.
51. Balserak BI, Zhu B, Grandner MA, Jackson N, Pien GW. Obstructive sleep apnea in pregnancy: performance of a rapid screening tool. Sleep Breath. 2019;23(2):425-32.
52. Lomakova YD, Chen X, Stein TP, Steer RA. Decreased Adiponectin Levels in Early Pregnancy Are Associated with High Risk of Prematurity for African American Women. Journal of clinical medicine. 2022;11(11).
53. Chen X, Scholl TO, Stein TP, Steer RA, Williams KP. Maternal Circulating Lipid Profile during Early Pregnancy: Racial/Ethnic Differences and Association with Spontaneous Preterm Delivery. Nutrients. 2017;9(1).
54. Manuck TA. Racial and ethnic differences in preterm birth: A complex, multifactorial problem. Semin Perinatol. 2017;41(8):511-8.
55. Huesch M, Doctor JN. Factors associated with increased cesarean risk among African American women: evidence from California, 2010. Am J Public Health. 2015;105(5):956-62.
56. Aron DC, Gordon HS, DiGiuseppe DL, Harper DL, Rosenthal GE. Variations in risk-adjusted cesarean delivery rates according to race and health insurance. Med Care. 2000;38(1):35-44.
57. Sakala C, Belanoff C, Declercq ER. Factors Associated with Unplanned Primary Cesarean Birth: Secondary Analysis of the Listening to Mothers in California Survey. BMC Pregnancy Childbirth. 2020;20(1):462.
58. Hoxha I, Braha M, Syrogiannouli L, Goodman DC, Juni P. Caesarean section in uninsured women in the USA: systematic review and meta-analysis. BMJ Open. 2019;9(3):e025356.
59. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflammatory bowel diseases. 2011;17(7):1573-80.
60. Selinger CP, Ghorayeb J, Madill A. What Factors Might Drive Voluntary Childlessness (VC) in Women with IBD? Does IBD-specific Pregnancy-related Knowledge Matter? J Crohns Colitis. 2016;10(10):1151-8.
61. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflammatory bowel diseases. 2009;15(5):720-5.
62. Elkafrawi D, Sisti G, Araji S, Khoury A, Miller J, Rodriguez Echevarria B. Risk Factors for Neonatal/Maternal Morbidity and Mortality in African American Women with Placental Abruption. Medicina (Kaunas). 2020;56(4).
63. Kinser PA, Jallo N, Amstadter AB, Thacker LR, Jones E, Moyer S, et al. Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic. Journal of women's health. 2021;30(5):654-64.
64. Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, et al. Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional Study. J Crohns Colitis. 2018;12(6):702-9.
65. Dove-Medows E, Deriemacker A, Dailey R, Nolan TS, Walker DS, Misra DP, et al. Pregnant African American Women's Perceptions of Neighborhood, Racial Discrimination, and Psychological Distress as Influences on Birth Outcomes. MCN Am J Matern Child Nurs. 2020;45(1):49-56.
66. Zhang M, Wan P, Ng K, Singh K, Cheng TH, Velickovic I, et al. Preeclampsia Among African American Pregnant Women: An Update on Prevalence, Complications, Etiology, and Biomarkers. Obstet Gynecol Surv. 2020;75(2):111-20.
67. Mileski MR, Shirey MR, Patrician PA, Childs G. Perceived Racial Discrimination in the Pregnant African American Population: A Concept Analysis. ANS Adv Nurs Sci. 2021;44(4):306-16.
68. Pinder M, Lummis K, Selinger CP. Managing inflammatory bowel disease in pregnancy: current perspectives. Clinical and experimental gastroenterology. 2016;9:325-35.
69. Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M. State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. Inflammatory bowel diseases. 2016;22(7):1609-15.
70. Mahadevan U. How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities. Gastroenterology. 2017;152(8):1813-6.
71. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019;156(5):1508-24.
72. Herman AM HA, James SD3, Ballard BR, M'Koma AE. Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations. Japanise Journal of Gastroenterology and Hepatology. 2020;3(2):1-11.
73. Body C, Christie JA. Gastrointestinal Diseases in Pregnancy: Nausea, Vomiting, Hyperemesis Gravidarum, Gastroesophageal Reflux Disease, Constipation, and Diarrhea. Gastroenterol Clin North Am. 2016;45(2):267-83.
74. Passi M MC, Marie B. P-090 African-American Women with Inflammatory Bowel Disease Deliver More Low Birth Weight Infants than White Women. Inflammatory Bowel Diseases 2014(1):S63-S4.
75. Johnson JE, Roman L, Key KD, Meulen MV, Raffo JE, Luo Z, et al. Study protocol: The Maternal Health Multilevel Intervention for Racial Equity (Maternal Health MIRACLE) Project. Contemp Clin Trials. 2022;120:106894.
76. Alio AP, Dillion T, Hartman S, Johnson T, Turner S, Bullock S, et al. A Community Collaborative for the Exploration of Local Factors Affecting Black Mothers' Experiences with Perinatal Care. Matern Child Health J. 2022;26(4):751-60.
77. Gillespie SL, Christian LM, Mackos AR, Nolan TS, Gondwe KW, Anderson CM, et al. Lifetime stressor exposure, systemic inflammation during pregnancy, and preterm birth among Black American women. Brain Behav Immun. 2022;101:266-74.
78. Suresh S, Amegashie C, Patel E, Nieman KM, Rana S. Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia. Curr Hypertens Rep. 2022;24(4):87-93.
79. Cochrane KM, Hutcheon JA, Karakochuk CD. Iron-Deficiency Prevalence and Supplementation Practices Among Pregnant Women: A Secondary Data Analysis From a Clinical Trial in Vancouver, Canada. J Nutr. 2022;152(10):2238-44.
80. Jun S, Gahche JJ, Potischman N, Dwyer JT, Guenther PM, Sauder KA, et al. Dietary Supplement Use and Its Micronutrient Contribution During Pregnancy and Lactation in the United States. Obstet Gynecol. 2020;135(3):623-33.
81. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106.
82. Herfarth HH, Kappelman MD, Long MD, Isaacs KL. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases. Inflammatory bowel diseases. 2016;22(1):224-33.
83. Dignass AU, Gasche C, Bettenworth D, Birgegard G, Danese S, Gisbert JP, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-22.
84. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58(2):229-37.
85. Sahyoun LC, Gaidos JKJ. A Practical Approach to IBD Care in the Pregnant Patient. Curr Gastroenterol Rep. 2022.
86. Vieujean S, De Vos M, Paridaens K, Daftary GS, Danese S, Peyrin-Biroulet L. Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: a systematic review. J Crohns Colitis. 2022.
87. Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, et al. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. J Crohns Colitis. 2022.
88. Manosa M, Navarro-Llavat M, Marin L, Zabana Y, Cabre E, Domenech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol. 2013;48(4):427-32.
89. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut. 1984;25(1):52-6.
90. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut. 1980;21(6):469-74.
91. Lindhagen T, Bohe M, Ekelund G, Valentin L. Fertility and outcome of pregnancy in patients operated on for Crohn's disease. Int J Colorectal Dis. 1986;1(1):25-7.
92. De Dombal FT, Burton IL, Goligher JC. Crohn's disease and pregnancy. Br Med J. 1972;3(5826):550-3.
93. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut. 1986;27(7):821-5.
94. Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorectal Dis. 1997;12(4):220-4.
95. Arkuran C, McComb P. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol. 2000;27(1):12-3.
96. M'Koma AE. Observation on essential biochemical data profile in connection with restorative proctocolectomy in humans. Vitamin B12 and fat absorption cited. Dissertation Thesis. 2001:1-126.
97. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55(11):1575-80.
98. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56(6):830-7.
99. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS. Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis. 2011;26(11):1365-74.
100. Tulchinsky H, Averboukh F, Horowitz N, Rabau M, Klausner JM, Halpern Z, et al. Restorative proctocolectomy impairs fertility and pregnancy outcomes in women with ulcerative colitis. Colorectal Dis. 2013;15(7):842-7.
101. Hull TL, Joyce MR, Geisler DP, Coffey JC. Adhesions after laparoscopic and open ileal pouch-anal anastomosis surgery for ulcerative colitis. Br J Surg. 2012;99(2):270-5.
102. Beyer-Berjot L, Maggiori L, Birnbaum D, Lefevre JH, Berdah S, Panis Y. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg. 2013;258(2):275-82.
103. Bartels SA, D'Hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256(6):1045-8.
104. Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):847-53.
105. Vieujean S, De Vos M, D'Amico F, Paridaens K, Daftary G, Dudkowiak R, et al. Inflammatory bowel disease meets fertility: A physician and patient survey. Dig Liver Dis. 2023.
106. Huang VW, Chang HJ, Kroeker KI, Goodman KJ, Hegadoren KM, Dieleman LA, et al. Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? Can J Gastroenterol Hepatol. 2015;29(2):95-103.
107. Hardeman RR, Karbeah J, Kozhimannil KB. Applying a critical race lens to relationship-centered care in pregnancy and childbirth: An antidote to structural racism. Birth. 2020;47(1):3-7.
108. Hardeman RR, Karbeah J. Examining racism in health services research: A disciplinary self-critique. Health Serv Res. 2020;55 Suppl 2(Suppl 2):777-80.
109. Jones CP. Levels of racism: a theoretic framework and a gardener's tale. Am J Public Health. 2000;90(8):1212-5.
110. Williams DR, Sternthal M. Understanding racial-ethnic disparities in health: sociological contributions. J Health Soc Behav. 2010;51 Suppl(Suppl):S15-27.
111. Cushing L, Faust J, August LM, Cendak R, Wieland W, Alexeeff G. Racial/Ethnic Disparities in Cumulative Environmental Health Impacts in California: Evidence From a Statewide Environmental Justice Screening Tool (CalEnviroScreen 1.1). Am J Public Health. 2015;105(11):2341-8.
112. Moriya AS, Chakravarty S. Racial And Ethnic Disparities In Preventable Hospitalizations And ED Visits Five Years After ACA Medicaid Expansions. Health affairs. 2023;42(1):26-34.
113. Braveman PA AE, Proctor D, Kauh T, Holm N. Systemic And Structural Racism:Definitions, Examples, HealthDamages, and Approaches To Dismantling. Health affairs. 2022;41(2):171-8.
114. Kauh TJ, Read JG, Scheitler AJ. The Critical Role of Racial/Ethnic Data Disaggregation for Health Equity. Popul Res Policy Rev. 2021;40(1):1-7.
115. Bailey ZD, Krieger N, Agenor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-63.
116. Camara P, Jones. Confronting Institutionalized Racism: Clark Atlanta University; 2002.
117. Chirwa S, Nwabuisi CR, Ladson GM, Korley L, Whitty JE, Atkinson R, et al. Poor Sleep Quality Is Associated with Higher Hemoglobin A1c in Pregnant Women: A Pilot Observational Study. International journal of environmental research and public health. 2018;15(10).
118. Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11(8):965-71.
119. Sobolewska-Wlodarczyk A, Wlodarczyk M, Banasik J, Gasiorowska A, Wisniewska-Jarosinska M, Fichna J. Sleep disturbance and disease activity in adult patients with inflammatory bowel diseases. J Physiol Pharmacol. 2018;69(3).
120. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22(11):1748-53.
121. Vedamurthy A, Ananthakrishnan AN. Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019;15(2):72-82.
122. Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflammatory bowel diseases. 2019;25(5):843-52.
123. Francis B, Klebanoff M, Oza-Frank R. Racial discrimination and perinatal sleep quality. Sleep Health. 2017;3(4):300-5.
124. Cohen MF, Corwin EJ, Johnson DA, Amore AD, Brown AL, Barbee NR, et al. Discrimination is associated with poor sleep quality in pregnant Black American women. Sleep Med. 2022;100:39-48.
125. Alhalel J, Patterson L, Francone NO, Danner S, Osei C, O'Brian CA, et al. Addressing racial disparities in perinatal care for African American/Black individuals in the Chicago community health setting: a qualitative study. BMC Pregnancy Childbirth. 2022;22(1):771.
126. Marinelli C, Savarino EV, Marsilio I, Lorenzon G, Gavaruzzi T, D'Inca R, et al. Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study. Sci Rep. 2020;10(1):507.
127. Nassikas N, Malhame I, Miller M, Bourjeily G. Pulmonary Considerations for Pregnant Women. Clin Chest Med. 2021;42(3):483-96.
128. Holdcroft A, Bevan DR, O'Sullivan JC, Sykes MK. Airway closure and pregnancy. Anaesthesia. 1977;32(6):517-23.
129. Middleton PG. Obstructive sleep apnoea and sleep disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2022;85(Pt A):107-13.
130. Brown NT, Turner JM, Kumar S. The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol. 2018;219(2):147-61 e1.
131. Oyiengo D, Louis M, Hott B, Bourjeily G. Sleep disorders in pregnancy. Clin Chest Med. 2014;35(3):571-87.
132. Franklin KA, Holmgren PA, Jonsson F, Poromaa N, Stenlund H, Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest. 2000;117(1):137-41.
133. O'Brien LM, Bullough AS, Chames MC, Shelgikar AV, Armitage R, Guilleminualt C, et al. Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG : an international journal of obstetrics and gynaecology. 2014;121(13):1685-93.
134. Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med. 2000;162(1):252-7.
135. Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep. 2004;27(1):79-84.
136. Pilkington S, Carli F, Dakin MJ, Romney M, De Witt KA, Dore CJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74(6):638-42.
137. Sedov ID, Cameron EE, Madigan S, Tomfohr-Madsen LM. Sleep quality during pregnancy: A meta-analysis. Sleep Med Rev. 2018;38:168-76.
138. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-5.
139. Blyton DM, Skilton MR, Edwards N, Hennessy A, Celermajer DS, Sullivan CE. Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep. 2013;36(1):15-21.
140. Garbazza C, Hackethal S, Riccardi S, Cajochen C, Cicolin A, D'Agostino A, et al. Polysomnographic features of pregnancy: A systematic review. Sleep Med Rev. 2020;50:101249.
141. Carvalho KM, Figueiredo M, Galindo Neto NM, Sa GGM, Silva C, Mendes PN. Comparison of the effectiveness of two educational interventions on sleep quality in older adults: a randomized clinical trial. Rev Esc Enferm USP. 2022;56:e20220326.
142. Singh AH, Bathla M, Gupta P, Bhusri L. Quality of sleep and disability associated with headache: migraine versus tension-type headache: A comparative study. Ann Afr Med. 2023;22(1):11-7.
143. Sweeney BM, Signal TL, Babbage DR. Effect of a behavioral-educational sleep intervention for first-time mothers and their infants: pilot of a controlled trial. J Clin Sleep Med. 2020;16(8):1265-74.
144. Ladyman C, Gander P, Huthwaite M, Sweeney B, Signal TL. Sleep HAPi: A Feasibility and Descriptive Analysis of an Early and Longitudinal Sleep Education Intervention for Pregnant Women. Behav Sleep Med. 2021;19(4):427-44.
145. Gessesse DN, Tsega NT, Aklil MB, Temesgan WZ, Abegaz MY, Anteneh TA, et al. Prevalence and associated factors of poor sleep quality among postpartum women in North West Ethiopia: a community-based study. BMC Psychiatry. 2022;22(1):538.
146. Lucchini M, O'Brien LM, Kahn LG, Brennan PA, Glazer Baron K, Knapp EA, et al. Racial/ethnic disparities in subjective sleep duration, sleep quality, and sleep disturbances during pregnancy: an ECHO study. Sleep. 2022;45(9).
147. Felix NAR, Ceolim MF. Sleep in pregnancy quarters: a longitudinal study. Rev Gaucha Enferm. 2022;44:e20210278.
148. Cai YM, Zheng XL, Shen ZM, Zhou BF, Liu YM, Yang JY, et al. Study on the sleep quality of women pregnant with a second child and the influencing factors. Eur J Med Res. 2022;27(1):207.
149. Wirth MD, Liu J, Wallace MK, McLain AC, Turner-McGrievy GM, Davis JE, et al. Dietary Inflammatory Index and sleep quality and duration among pregnant women with overweight or obesity. Sleep. 2022;45(12).
150. Lau Y, Cheng LJ, Chee DGH, Zhao M, Wong SH, Wong SN, et al. High body mass index and sleep problems during pregnancy: A meta-analysis and meta-regression of observational studies. J Sleep Res. 2022;31(1):e13443.
151. Ghante A, Raj JP, Krishna B, Thomas A. Prevalence and predictors of sleep deprivation and poor sleep quality and their associated perinatal outcomes during the third trimester of pregnancy. J Taibah Univ Med Sci. 2021;16(3):359-64.
152. Cao V, Makarem N, Maguire M, Samayoa I, Xi H, Liang C, et al. History of Weight Cycling Is Prospectively Associated With Shorter and Poorer-Quality Sleep and Higher Sleep Apnea Risk in Diverse US Women. J Cardiovasc Nurs. 2021;36(6):573-81.
153. Papadopoulou SK, Mantzorou M, Voulgaridou G, Pavlidou E, Vadikolias K, Antasouras G, et al. Nutritional Status Is Associated with Health-Related Quality of Life, Physical Activity, and Sleep Quality: A Cross-Sectional Study in an Elderly Greek Population. Nutrients. 2023;15(2).
154. Bei B, Pinnington DM, Shen L, Blumfield M, Drummond SPA, Newman LK, et al. A scalable cognitive behavioural program to promote healthy sleep during pregnancy and postpartum periods: protocol of a randomised controlled trial (the SEED project). BMC Pregnancy Childbirth. 2019;19(1):254.
155. Rezaei E, Moghadam ZB, Nejat S, Dehghannayeri N. The impact of sleep healthy behavior education on the quality of life in the pregnant women with sleep disorder: A randomized control trial in the year 2012. Iran J Nurs Midwifery Res. 2014;19(5):508-16.
156. Hayase M, Shimada M, Seki H. Sleep quality and stress in women with pregnancy-induced hypertension and gestational diabetes mellitus. Women Birth. 2014;27(3):190-5.
157. Umeno S, Kato C, Nagaura Y, Kondo H, Eto H. Characteristics of sleep/wake problems and delivery outcomes among pregnant Japanese women without gestational complications. BMC Pregnancy Childbirth. 2020;20(1):179.
158. Felder JN, Roubinov D, Zhang L, Gray M, Beck A. Endorsement of a single-item measure of sleep disturbance during pregnancy and risk for postpartum depression: a retrospective cohort study. Arch Womens Ment Health. 2023.
159. Baattaiah BA, Alharbi MD, Babteen NM, Al-Maqbool HM, Babgi FA, Albatati AA. The relationship between fatigue, sleep quality, resilience, and the risk of postpartum depression: an emphasis on maternal mental health. BMC Psychol. 2023;11(1):10.
160. Brekke M, Amro A, Smastuen MC, Glavin K, Solberg B, Oygarden AU, et al. Quality of life in Norwegian pregnant women and men with pregnant partners, and association with perception of sleep and depressive symptoms: a cross-sectional study. BMC Pregnancy Childbirth. 2023;23(1):37.
161. Vanderlinden J, Boen F, van Uffelen JGZ. Effects of physical activity programs on sleep outcomes in older adults: a systematic review. Int J Behav Nutr Phys Act. 2020;17(1):11.
162. Das S, Roy RN, Das DK, Chakraborty A, Mondal R. Sleep Quality and its various correlates: A community-based study among geriatric population in a community development block of Purba Bardhaman district, West Bengal. J Family Med Prim Care. 2020;9(3):1510-6.
163. Ngui EM, Warner TD, Roberts LW. Perceptions of African-American health professionals and community members on the participation of children and pregnant women in genetic research. Public Health Genomics. 2014;17(1):23-32.
164. Thomas SB, Fine MJ, Ibrahim SA. Health disparities: the importance of culture and health communication. Am J Public Health. 2004;94(12):2050.
165. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295-309.
166. Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV, Jr. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol. 2019;12:1756284819827692.
167. Misra R, Faiz O, Munkholm P, Burisch J, Arebi N. Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups. World J Gastroenterol. 2018;24(3):424-37.
168. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012-23.
169. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflammatory bowel diseases. 2007;13(12):1529-35.
170. Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105(10):2202-8.
171. Nguyen GC, Bouchard S, Diong C, Promoting A, Care through Centres of Excellence N. Access to Specialists and Emergency Department Visits in Inflammatory Bowel Disease: A Population-Based Study. J Crohns Colitis. 2019;13(3):330-6.
172. Habal FM, Huang VW. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther. 2012;35(5):501-15.
173. Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med. 2020;13(2):62-9.
174. Evans LM, Myers MM, Monk C. Pregnant women's cortisol is elevated with anxiety and depression - but only when comorbid. Arch Womens Ment Health. 2008;11(3):239-48.
175. Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther. 2011;34(7):724-34.
176. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102(9):1947-54.
177. Hatch Q, Champagne BJ, Maykel JA, Davis BR, Johnson EK, Bleier JS, et al. Crohn's disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum. 2014;57(2):174-8.
178. van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9(2):107-24.
179. Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther. 2011;34(2):125-45.
180. Schulze H, Esters P, Dignass A. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation. Aliment Pharmacol Ther. 2014;40(9):991-1008.
181. Tremblay E, Therasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics. 2012;32(3):897-911.
182. Haq AI, Sahai A, Hallwoth S, Rampton DS, Dorudi S. Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature. Int J Colorectal Dis. 2006;21(5):465-9.
183. Overbey D, Govekar H, Gajdos C. Surgical management of colonic perforation due to ulcerative colitis during pregnancy: Report of a case. World journal of gastrointestinal surgery. 2014;6(10):201-3.
184. Naganuma M, Kunisaki R, Yoshimura N, Nagahori M, Yamamoto H, Kimura H, et al. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. J Crohns Colitis. 2011;5(4):317-23.
185. Nielsen OH, Gubatan JM, Juhl CB, Streett SE, Maxwell C. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(1):74-87 e3.
186. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Am J Obstet Gynecol. 2019;220(4):308-23.
187. Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(5):460-6.
188. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387-411.
189. Ronchetti C, Cirillo F, Di Segni N, Cristodoro M, Busnelli A, Levi-Setti PE. Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review. Nutrients. 2022;14(8).
190. Seifarth C, Ritz JP, Pohlen U, Kroesen AJ, Siegmund B, Frericks B, et al. Therapy of complicated Crohn's disease during pregnancy--an interdisciplinary challenge. Int J Colorectal Dis. 2014;29(6):645-51.
191. Walldorf J, Zwirnmann K, Seufferlein T. [Pregnancy and inflammatory bowel disease]. Internist (Berl). 2011;52(1):76, 8-80.
192. van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, et al. Modulation of cytokine patterns and microbiome during pregnancy in IBD. Gut. 2020;69(3):473-86.
193. Kim ES, Tarassishin L, Eisele C, Barre A, Nair N, Rendon A, et al. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies. Gastroenterology. 2021;160(4):1118-30 e3.
194. Toomey D, Waldron B. Family planning and inflammatory bowel disease: the patient and the practitioner. Fam Pract. 2013;30(1):64-8.
195. Walldorf J, Pijan E, Greinert R, Riesner-Wehner A, Michl P. Family planning with inflammatory bowel disease: the challenge of childlessness and parent concerns. Z Gastroenterol. 2021;59(8):841-50.
196. Flanagan E, Wright EK, Sparrow MP, Moore GT, Connell WR, De Cruz P, et al. A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflammatory bowel diseases. 2021;27(12):1909-18.
197. Tsuda S, Sameshima A, Sekine M, Kawaguchi H, Fujita D, Makino S, et al. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. Mod Rheumatol. 2020;30(5):852-61.
198. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer L. Disease-related pregnancy concerns and reproductive planning in women with inflammatory bowel diseases. J Fam Plann Reprod Health Care. 2015;41(4):272-7.
199. Gawron LM, Hammond C, Keefer L. Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases. Patient Educ Couns. 2014;94(1):134-7.
200. Steinlauf AF, Present DH. Medical management of the pregnant patient with inflammatory bowel disease. Gastroenterol Clin North Am. 2004;33(2):361-85, xi.
201. Dos Santos Marques IC, Theiss LM, Baker SJ, Liwo A, Wood LN, Cannon JA, et al. Low Health Literacy Exists in the Inflammatory Bowel Disease (IBD) Population and Is Disproportionately Prevalent in Older African Americans. Crohns Colitis 360. 2020;2(4).
202. Dos Santos Marques IC, Herbey, II, Theiss LM, Shao CC, Fouad MN, Scarinci IC, et al. Understanding the surgical experience for Black and White patients with inflammatory bowel disease (IBD): The importance of health literacy. Am J Surg. 2022;223(2):303-11.
203. Kaps L, Omogbehin L, Hildebrand K, Gairing SJ, Schleicher EM, Moehler M, et al. Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer. Sci Rep. 2022;12(1):21072.
204. Mehra R, Alspaugh A, Dunn JT, Franck LS, McLemore MR, Keene DE, et al. "'Oh gosh, why go?' cause they are going to look at me and not hire": intersectional experiences of black women navigating employment during pregnancy and parenting. BMC Pregnancy Childbirth. 2023;23(1):17.
205. Liese K, Stewart K, Pearson P, Lofton S, Mbande T, Patil C, et al. Melanated Group Midwifery Care: Centering the Voices of the Black Birthing Community. J Midwifery Womens Health. 2022;67(6):696-700.
206. Chaparro M, Donday MG, Abad-Santos F, Martin de Carpi FJ, Macia-Martinez MA, Montero D, et al. The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU. Therap Adv Gastroenterol. 2021;14:17562848211018097.
207. Laube R, Paramsothy S, Leong RW. Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis. Expert Opin Drug Saf. 2021;20(3):275-92.
208. Gubatan J, Nielsen OH, Levitte S, Juhl CB, Maxwell C, Streett SE, et al. Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2021;116(2):243-53.
209. Pedersen N, Bortoli A, Duricova D, R DI, Panelli MR, Gisbert JP, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38(5):501-12.
210. de Lima A, Zelinkova Z, Mulders AG, van der Woude CJ. Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy. Clin Gastroenterol Hepatol. 2016;14(9):1285-92 e1.
211. Friedman SH, Heneghan A, Rosenthal M. Characteristics of women who do not seek prenatal care and implications for prevention. J Obstet Gynecol Neonatal Nurs. 2009;38(2):174-81.
212. Clark EC, Cranston E, Polin T, Ndumbe-Eyoh S, MacDonald D, Betker C, et al. Structural interventions that affect racial inequities and their impact on population health outcomes: a systematic review. BMC Public Health. 2022;22(1):2162.
213. Jeffers NK, Berger BO, Marea CX, Gemmill A. Investigating the impact of structural racism on black birthing people - associations between racialized economic segregation, incarceration inequality, and severe maternal morbidity. Soc Sci Med. 2023;317:115622.
214. OjiNjideka Hemphill N, Crooks N, Zhang W, Fitter F, Erbe K, Rutherford JN, et al. Obstetric experiences of young black mothers: An intersectional perspective. Soc Sci Med. 2023;317:115604.
215. Gao X, Snowden JM, Tucker CM, Allen A, Morello-Frosch R, Abrams B, et al. Remapping racial and ethnic inequities in severe maternal morbidity: The legacy of redlining in California. Paediatr Perinat Epidemiol. 2022.
216. Maternal, Child Nutrition Study G, Group m, Black RE, Alderman H, Bhutta ZA, et al. Maternal and child nutrition: building momentum for impact. Lancet. 2013;382(9890):372-5.
217. Plaza-Diaz J, Ruiz-Ojeda FJ, Morales J, de la Torre AIC, Garcia-Garcia A, de Prado CN, et al. Effects of a Novel Infant Formula on Weight Gain, Body Composition, Safety and Tolerability to Infants: The INNOVA 2020 Study. Nutrients. 2022;15(1).
218. Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics. 2003;112(3 Pt 1):e177-83.
219. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4 Suppl 1:S17-30.
220. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflammatory bowel diseases. 2019;25(4):627-41.
221. Kokoszko-Bilska A, Sobkiewicz S, Fichna J. Inflammatory bowel diseases and reproductive health. Pharmacol Rep. 2016;68(4):859-64.
222. Selinger CP, Leong RW, Lal S. Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective. World J Gastroenterol. 2012;18(21):2600-8.
223. Maliszewska AM, Warska A, Cendrowski K, Sawicki W. Inflammatory bowel disease and pregnancy. Ginekol Pol. 2017;88(7):398-403.
224. Ellul P, Zammita SC, Katsanos KH, Cesarini M, Allocca M, Danese S, et al. Perception of Reproductive Health in Women with Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(8):886-91.
225. Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, et al. Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy. Patient. 2022;15(3):353-65.
226. Long MD, Siegel CA, Abraham BP, Chiorean M, Mahadevan U. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022;20(3):706-8 e1.
227. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, et al. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology. 2021;160(4):1131-9.
228. Bengtson MB, Aamodt G, Mahadevan U, Vatn MH. Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study. Inflammatory bowel diseases. 2017;23(7):1225-33.
229. Bengtson MB, Haugen M, Brantsaeter AL, Aamodt G, Vatn MH. Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort. BMC Gastroenterol. 2020;20(1):28.
230. Myklebust-Hansen T, Aamodt G, Haugen M, Brantsaeter AL, Vatn MH, Bengtson MB. Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa). Inflammatory bowel diseases. 2017;24(1):12-24.
231. Picardo S, Seow CH. A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy. Drugs. 2019;79(10):1053-63.
232. Horst S, Kane S. The use of biologic agents in pregnancy and breastfeeding. Gastroenterol Clin North Am. 2014;43(3):495-508.
233. Wang H, Hu Y, Chen F, Shen M. Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. BMC Pregnancy Childbirth. 2022;22(1):854.
234. Clowse M, Fischer-Betz R, Nelson-Piercy C, Scheuerle AE, Stephan B, Dubinsky M, et al. Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol. Ther Adv Musculoskelet Dis. 2022;14:1759720X221087650.
235. Wiersma TK, Visschedijk MC, de Boer NK, Lub-de Hooge MN, Prins JR, Touw DJ, et al. The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review. Pharmaceutics. 2022;14(6).
236. Wieringa JW, Driessen GJ, Van Der Woude CJ. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Expert Rev Gastroenterol Hepatol. 2018;12(8):811-8.
237. Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. Gastroenterology. 2018;155(3):696-704.
238. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018;16(1):99-105.
239. Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, et al. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. Gastroenterology. 2016;151(1):110-9.
240. Weiss B, Ben-Horin S, Lev A, Broide E, Yavzori M, Lahat A, et al. Immune function in newborns with in-utero exposure to anti-TNFalpha therapy. Front Pediatr. 2022;10:935034.
241. de Aragao MC, Beraldo RF, Marcondes MB, de Barros JR, Herrerias GSP, Saad-Hossne R, et al. Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review. Medicine (Baltimore). 2021;100(51):e28274.
242. Sako M, Yoshimura N, Sonoda A, Okano S, Ueda M, Tezuka M, et al. Safety Prediction of Infants Born to Mothers with Crohn's Disease Treated with Biological Agents in the Late Gestation Period. J Anus Rectum Colon. 2021;5(4):426-32.
243. Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology. 2016;150(3):734-57 e1.
244. Burke KE, Haviland MJ, Hacker MR, Shainker SA, Cheifetz AS. Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2017;23(5):721-6.
245. Foulon A, Dupas JL, Sabbagh C, Chevreau J, Rebibo L, Brazier F, et al. Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review. Inflammatory bowel diseases. 2017;23(5):712-20.
246. Brestfeeding So. Breast feeding anf thevuse of human milk. Pediatrics. 2012;129:e827-e41.
247. Brodribb W. ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018. Breastfeed Med. 2018;13(5):307-14.
248. Anderson PO. Drugs that Suppress Lactation, Part 2. Breastfeed Med. 2017;12:199-201.
249. Sezgin E, Terlemez G, Bozkurt B, Bengi G, Akpinar H, Buyuktorun I. Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. PeerJ. 2022;10:e14217.
250. Godny L, Svolos V, Williams AJ, Czuber-Dochan W, Aloi M, Ibarra A, et al. Multidisciplinary Perinatal Care in IBD. J Crohns Colitis. 2022.
251. Selinger CP, Nelson-Piercy C, Fraser A, Hall V, Limdi J, Smith L, et al. IBD in pregnancy: recent advances, practical management. Frontline Gastroenterol. 2021;12(3):214-24.
252. Feng Z, Kang G, Wang J, Gao X, Wang X, Ye Y, et al. Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023;158:114174.
253. AE MK. Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management. Medical Research Archives. 2023;11(1).
254. Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, et al. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(3):215-27.
255. Danese S, Vermeire S, D'Haens G, Panes J, Dignass A, Magro F, et al. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. Lancet Gastroenterol Hepatol. 2022;7(4):294-306.
256. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022;58(5).
257. M'Koma AE. Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis. 2006;21(7):711-20.
258. M'Koma AE, Wise PE, Muldoon RL, Schwartz DA, Washington MK, Herline AJ. Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones. Int J Colorectal Dis. 2007;22(10):1143-63.
259. M'Koma AE, Lindquist K, Liljeqvist L. Biochemical laboratory data in patients before and after restorative proctocolectomy. A study on 83 patients with a follow-up of 36 months. Ann Chir. 1994;48(6):525-34.
260. M'Koma AE, Lindquist K, Liljeqvist L. Effect of restorative proctocolectomy on gastric acid secretion and serum gastrin levels: a prospective study. Dis Colon Rectum. 1999;42(3):398-402.
261. Ballard BR, M'Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis. World journal of gastrointestinal endoscopy. 2015;7(7):670-4.
262. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, et al. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PloS one. 2017;12(8):e0179710.
263. M'Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World journal of gastrointestinal surgery. 2014;6(11):208-19.
264. Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, et al. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PloS one. 2021;16(3):e0246393.
265. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001;2(4):463-71.
266. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Jama. 1999;282(11):1054-60.
267. Tandon P, Natt N, Malhi G, Wong EC, Matthews P, Reinisch W, et al. Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis. Eur J Gastroenterol Hepatol. 2023;35(3):231-40.
268. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
269. Darie AM, Sinopoulou V, Ajay V, Bel Kok K, Patel KV, Limdi J, et al. BSG 2024 IBD guidelines protocol (standard operating procedures). BMJ Open Gastroenterol. 2023;10(1).
270. Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11(6):649-70.
271. Leenhardt R, Riviere P, Papazian P, Nion-Larmurier I, Girard G, Laharie D, et al. Sexual health and fertility for individuals with inflammatory bowel disease. World J Gastroenterol. 2019;25(36):5423-33.
272. Lee S, Crowe M, Seow CH, Kotze PG, Kaplan GG, Metcalfe A, et al. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database Syst Rev. 2019;7(7):CD012711.
273. Goto Y, Uchino M, Horio Y, Kusunoki K, Minagawa T, Kuwahara R, et al. Delivery Mode after Ileal Pouch-Anal Anastomosis among Pregnant Women with Ulcerative Colitis. J Anus Rectum Colon. 2021;5(4):419-25.
274. Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg. 2007;94(4):478-82.
275. Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47(7):1127-35.
276. Anderson BT, Ertle JT, Borum ML. Men with inflammatory bowel disease are rarely counseled regarding effects of immunosuppressive therapy on fertility and pregnancy. J Crohns Colitis. 2013;7(12):e716.
277. Roy A CC, Martin C, Kane SV, Dubinsky M, Sandborn WJ, Sands BE, Mahdevan U. Exposure to Biologic Therapy and Childhood Development among Offspring of Women with Inflammatory Bowel Disease: Results from the Piano Registry. Gastroenterology. 2017;152(5):S85-S6.
278. Khil J, Picardo S, Seow CH, Leung Y, Metcalfe A, Afshar EE, et al. Physiological and psychological stress in pregnant women with quiescent inflammatory bowel disease: A pilot study using salivary biomarkers. JGH Open. 2020;4(4):692-7.
279. Mikocka-Walus A, Pittet V, Rossel JB, von Kanel R, Swiss IBDCSG. Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016;14(6):829-35 e1.